A combined COVID-19 and flu vaccine is being developed in Australia, with researchers at Mater Hospital Brisbane leading the trial.
The protein-based jab can fight both influenza and COVID-19, while also being safe for people with weak immune systems, cancer or a history of the disease.
Leading the trial is Mater's Director of Infectious Diseases, Professor Paul Griffin, who said, "providing people with the option of an approved combination vaccine will help with vaccine uptake as there will be no need for two jabs".
He said the new vaccine could appeal to people who cannot or do not want to have an mRNA jab.
The above article was sent to subscribers in Pharmacy Daily's issue from 16 Oct 24
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 16 Oct 24
